Stride Expands Across the Midwest, Celebrating its Tenth Center in Iowa and Sixth in Nebraska ...

MISSISSAUGA, Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- The College of Family Physicians of Canada (CFPC) is calling on all federal political parties to commit to actions that protect and strengthen ...

AIAW 2025 Runs April 7-11 to Encourage Well-Visits and Recommended Immunizations ...

InfiniSurg, LLC is recognized for its patient-centric approach and commitment to innovation in outpatient surgical care. The addition of CompuFlo® reflects InfiniSurg’s focus on leveraging advanced ...

The start of patient dosing represents a huge milestone for Moleculin and importantly, the AML community,” commented Walter Klemp, Chairman and Chief Executive Officer of Moleculin. “Our team remains ...

Cardarine GW501516 is universally recognized as the most effective SARM for cutting and fat loss. Known for its ability to ...

A link to the live and archived webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. An archive of the webcast will be available for three months.

Qualigen and Marizyme have entered an MOU dated March 28, 2025. This is the logical next step in acquiring Marizyme, following on our co-marketing agreement established in 2024. Upon completion of ...

Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule ...

A fireside chat at the Stifel 2025 Virtual Targeted Oncology Forum at 10:00 a.m. ET on Wednesday, April 9, 2025. A live webcast will be available using this weblink: ...

SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced the execution of a planned ...

Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented biomarker results from the ...